ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » California » Pediatrics

Top Pediatrics Prescribers in California

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
BELLA NUDEL M.D.

Pediatrics

20,889

$1.39M

635
599 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

14%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 26%

$66
Average prescription price

Avg: $57

MONICA CEPIN MD

Pediatrics

13,669

$730K

722
623 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

7%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$53
Average prescription price

Avg: $57

DE LE MD

Pediatrics

7,242

$368K

337
290 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

16%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 26%

$51
Average prescription price

Avg: $57

UYEN BUI M.D.

Pediatrics

7,166

$421K

1548
1270 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 26%

$59
Average prescription price

Avg: $57

S. MOHAMMAD MARASHI M.D.

Pediatrics

6,915

$775K

6238
5374 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

100%
prescriptions for brand name drugs

Avg: 26%

$112
Average prescription price

Avg: $57

JOHN SARKARIA M.D.

Pediatrics

5,959

$274K

294
245 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$46
Average prescription price

Avg: $57

MICHELE VIOLICH MD

Pediatrics

5,686

$326K

436
248 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

14%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 26%

$57
Average prescription price

Avg: $57

TAN NGUYEN M.D.

Pediatrics

5,544

$279K

112
100 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

24%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 26%

$50
Average prescription price

Avg: $57

GRADY FORT M.D.

Pediatrics

5,210

$292K

287
154 are 65+

26%
patients receiving schedule two controlled substances

Avg: 2%

25%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$56
Average prescription price

Avg: $57

JESSELY ORPILLA M.D.

Pediatrics

4,217

$270K

195
178 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

20%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$64
Average prescription price

Avg: $57

JOSE DIAZ M.D

Pediatrics

3,876

$203K

219
168 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$52
Average prescription price

Avg: $57

RENE LIM M.D.

Pediatrics

3,840

$245K

325
296 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 26%

$64
Average prescription price

Avg: $57

CHARLES QUEST MD

Pediatrics

3,696

$157K

130
112 are 65+

8%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$42
Average prescription price

Avg: $57

ANTONIO GARCIA MD

Pediatrics

3,359

$108K

174
130 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

14%
patients receiving schedule three controlled substances

Avg: 7%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 26%

$32
Average prescription price

Avg: $57

NHAT VO M.D.

Pediatrics

3,023

$121K

190
153 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

12%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 26%

$40
Average prescription price

Avg: $57

HANSON WONG M.D.

Pediatrics

2,946

$137K

181
146 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$47
Average prescription price

Avg: $57

RAJESWARI SIDHARAJU MD

Pediatrics

2,925

$163K

82
20 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 26%

$56
Average prescription price

Avg: $57

PARVANEH RAFAELOFF MD

Pediatrics

2,877

$140K

85
72 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

15%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 26%

$49
Average prescription price

Avg: $57

HAMID MALAKOOTI M.D.

Pediatrics

2,786

$120K

176
116 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

18%
patients receiving schedule three controlled substances

Avg: 7%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 26%

$43
Average prescription price

Avg: $57

EDWARD AUSTIN M.D.

Pediatrics

2,742

$81.6K

139
53 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

42%
patients receiving schedule three controlled substances

Avg: 7%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 26%

$30
Average prescription price

Avg: $57

ESTEBAN PONI M.D.

Pediatrics

2,715

$131K

229
154 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 26%

$48
Average prescription price

Avg: $57

BA TRAN MD

Pediatrics

2,577

$134K

138
65 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 26%

$52
Average prescription price

Avg: $57

SHARON RIESEN M.D.

Pediatrics

2,501

$169K

55
13 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$68
Average prescription price

Avg: $57

HITESH PATEL MD

Pediatrics

2,353

$120K

228
181 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

8%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$51
Average prescription price

Avg: $57

MOHAMMED BAILONY MD

Pediatrics

2,134

$135K

106
84 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 26%

$63
Average prescription price

Avg: $57

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank